Ocular Hypertension Completed Phase 2 Trials for Bimatoprost (DB00905)

Also known as: Hypertension Ocular / Intraocular pressure high / Intraocular hypertension / Intraocular pressure raised / Ocular Hypertension (OHT) / Ocular Hypertension (OH) / Hypertension, Ocular / Elevated Intraocular Pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02358369Dose-Ranging Study of the Bimatoprost Ocular InsertTreatment
NCT02537015An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular InsertTreatment
NCT02143843An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 ProductTreatment
NCT01915940Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionTreatment
NCT00651859Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00538304A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular HypertensionTreatment
NCT01110499Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionTreatment
NCT01001195Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic SolutionTreatment
NCT01016691Safety and Efficacy of a Drug Delivery System in GlaucomaTreatment
NCT01291108Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01863953A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular HypertensionTreatment
NCT00652496Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular HypertensionTreatment